Annual Drug Patent Expirations for ABILIFY
Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is included in seven NDAs. It is available from one supplier. There are fifty patents protecting this drug and three Paragraph IV challenges.
Drug patent litigation for ABILIFY.
This drug has eigthy-three patent family members in thirty-four countries.
The generic ingredient in ABILIFY is aripiprazole. One supplier is listed for this compound. Additional details are available on the aripiprazole profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
